ARCT - Arcturus Therapeutics GAAP EPS of -$1.33 beats by $0.44 revenue of $13.4M beats by $9.31M
- Arcturus Therapeutics press release ( NASDAQ: ARCT ): Q3 GAAP EPS of -$1.33 beats by $0.44 .
- Revenue of $13.4M (+449.2% Y/Y) beats by $9.31M .
- The Company’s cash balance totaled $237.7M as of September 30, 2022, compared to a cash balance of $370.5M at December 31, 2021.
For further details see:
Arcturus Therapeutics GAAP EPS of -$1.33 beats by $0.44, revenue of $13.4M beats by $9.31M